Approval enhances the Company's ability to receive, prepare, and deploy pediatric-focused medical materials in support of state and local public health initiatives
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
V.F. Corporation remains rated Hold as growth returns and deleveraging continues, but weak consumer confidence poses a near-term headwind. Recent earnings highlight brand-level growth metrics and revenue trends, with a focus on how each brand contributed to overall performance. Progress on net debt reduction is noted, supporting the ongoing deleveraging narrative and financial stability.